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ET-1, promoted the pathophysiological phenotypes of HCM in the iPSC-
derived cardiomyocytes.
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Background: Experimental autoimmune myocarditis (EAM) is
a mouse model of inﬂammatory cardiomyopathy. The amount of
endothelin (ET) increases according to the disease progression;
however, the pathological role of ET in myocarditis has not been
elucidated. Methods and results: EAM was induced by immunization
of cardiac myosin peptide with complete Freund's adjuvant on days
0 and 7 in BALB/c mice. ET-A/-B dual receptor antagonist SB209670
was administered by continuous infusion from a subcutaneous pump
for 3 weeks. An increase in heart-to-body weight ratio was observed
in SB209670-treated mice compared with vehicle-treated mice. The
heart pathology in SB209670-treated mice was remarkable for gross
inﬂammatory inﬁltration, in contrast to the smaller inﬂammation in
the hearts of vehicle-treated mice. We found that ET blockade
decreased the number of Foxp3+ regulatory T cells and inhibited the
production of immunoregulatory cytokine IL-10 in the heart. ET
blockade also inhibited the expression of suppressor of cytokine
signaling 3 (SOCS3) that plays a key role in the negative regulation of
both Toll-like receptor (TLR)- and cytokine receptor-mediated
signaling. EAM is a CD4+ T cell-mediated disease. CD4+ T cells
isolated from SB209670-treated EAM mice produced less IL-10 and
more inﬂammatory cytokines IFN-γ and IL-17 than those isolated
from vehicle-treated mice. Conclusions: ET receptor antagonist
exacerbated autoimmune myocarditis in mice. ET may play an
important role in the regulation of inﬂammation in myocarditis.
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In engineered cells, endothelin ETA- and ETB-receptors can
heterodimerize. We tested whether this is possible in native tissue.
Therefore, rat mesenteric resistance arteries were maintained in organ
culture for 24 h to upregulate ETB-mediated contractions in addition to
their normal ETA-mediated constrictions. Thereafter the vessels were
cannulated and maintained at constant distending pressure and 37 °C
under a two photon laser scanning microscope. They were then sub-
sequently exposed to ﬁrst 100 nM linear ET-1 (ETB-agonist) taggedwith
Oregon Green 488 (OG488) and then to 16 nM intact ET-1 (ETA/ETB-
agonist) tagged with the rhodamine dye TAMRA. After incubation with
the labeled ligands, the arterial smooth muscle cells in the tunica media
were efﬁciently stained and became visible under the two photon
microscope. Wrinkling of the autoﬂuorescent internal and external
elastic laminae accompanied agonist-induced constriction. TAMRA-ET-1
bound to all smooth muscle cells with a homogeneous cytoplasmic
distributionwhereas similar staining was observed for labeled linear ET-
1 but only on some group of cells. Fluorescence lifetime measurements
were employed to probe the interaction of the two receptor subtypes.
Fluorescence lifetime of OG488, which acted as a donor, was reduced
in the presence of TAMRA, from 2.8 ps to 2.3 ps, which indicates a
ﬂuorescence resonant energy transfer (FRET ), a phenomenonwhich can
take place only if the receptors are in close proximity (b10 nm). The
methodology that is introduced by these preliminary observations may
be useful to asses ET-receptor heterodimerization in biopsies from
relevant experimental animal models and human patients.
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In preclinical heart failure (HF) models, endothelin receptor A (ETA)
antagonists (ETAi) attenuated the disease progression. However, clinical
HF trials failed to demonstrate beneﬁcial effects on cardiac function
and prognosis. We hypothesized that established HF drugs such as
adrenergic receptor blockers interfere with the mechanism of action of
ETAi. Here we report, that mice lacking ETA selectively in sympathetic
neurons (SN-KO) showed less adverse structural remodeling and cardiac
dysfunction in response to pathological pressure overload induced by
transverse aortic constriction (TAC). In contrast, mice lacking ETA
selectively in cardiomyocytes (CM-KO) were not protected against HF.
TAC led to a disturbed sympathetic nerve function as measured by
cardiac norepinephrine (NE) tissue levels and [124I]-MIBG PET, which
was prevented in SN-KO. In co-cultures of cardiomyocytes (CMs) and
sympathetic neurons (SNs), endothelin-1 (ET1) led to a massive NE
release and exaggerated CM hypertrophy as compared to CM mono-
cultures. ETA-deﬁcient CMs gained a hypertrophic response through
wild type SNs but ETA-deﬁcient SNs failed to mediate exaggerated CM
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hypertrophy. Furthermore, ET1 mediated its effects indirectly via
NE in CM-SN co-cultures through adrenergic receptors and histone
deacetylases, resulting in activation of the pro-hypertrophic transcrip-
tion factorMEF2. In conclusion, sympathetic ETA ampliﬁes ET1 effects on
CMs through adrenergic neurotransmission. In accordance to our initial
hypothesis, anti-adrenergic therapies may blunt potential beneﬁcial
effects of ETAi. These ﬁndings call for a personalized strategy to identify
patients that could beneﬁt from ETAi.
doi:10.1016/j.lfs.2013.12.191
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The murine homologue to human chymase, the mouse Mast Cell
Protease-4 (mMCP-4), activates the pro-forms of angiotensin-II and
endothelin-1 (ET-1) in vivo; both peptides being well-established in
cardiovascular diseases. In the present study we postulated that mMCP-
4-dependent synthesis of ET-1 plays an important role in the
development of atherosclerosis in the Apolipoprotein E knock out
mouse model (ApoE KO). Peritoneal mast cells were collected from
C56BL/6J wild-type (WT), mMCP-4 KO and ApoE KO mice and their
granular contents were assayed for the enzymatic processing of the
ﬂuorogenic substrate Suc-Val-Val-Pro-Phe-amidomethylcoumarin. WT
and ApoE KO derived samples produced a TY-51469 (speciﬁc chymase
inhibitor) sensitive ﬂuorescence, but not in mMCP-4 KO samples.
Via HPLC detection, a TY-51469-sensitive conversion of big ET-1 to ET-
1 (1-31)wasmonitored inmast cell homogenates. Homogenate samples
from ApoE KO mice showed signiﬁcant increases in ET-1 (1-31)
production when compared to extracts from WT mice (milliAU × time
(s), WT: 763 ± 124; ApoE KO: 1756 ± 339, n = 7; P= 0.018). Finally,
Sudan IV staining of aortas from 27 to 30 week old male mice on chow
diet showed that the repression of mMCP-4 in APOE KO mice (APOE/
mMCP-4 dKO) reduced by 65% the atherosclerotic lesion area found in
ApoE KO mice (ApoE KO: 7.45 ± 1.31%; ApoE/mMCP-4 dKO: 2.67 ±
0.64%, n = 9–10, P = 0.004). These results suggest an increased con-
tribution role of mMCP-4 in the synthesis of ET-1 in mast cells derived
from ApoE KO mice and the pivotal role of that chymase isoform in the
development of atherosclerosis. (Funded by CIHR).
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